AVALIAÇÃO DA PARCERIA ENTRE INDÚSTRIA FARMACÊUTICA E
UNIVERSIDADE COMO ESTRATÉGIA PARA A INOVAÇÃO DE
MEDICAMENTOS NO BRASIL
Inovação tecnológica
Indústria farmacêutica
Medicamento
Brasil
Estratégia competitiva
Parceria universidade-indústria farmacêutica
Hélice-tríplice
Lei da Inovação
Governo
Competitive strategy innovation
University pharmaceutical industry partnership
Triple helix
Innovation
Innovation act
Medicine
Governanment
CNPQ::ENGENHARIAS::ENGENHARIA DE PRODUCAO
Abstract
Innovation is the keyword for the pharmaceutical sector. Strategically, innovation in product
is pivotal for companies to continue to be competitive in this sector, which is deemed as
essentially science-based. Brazil is one of the greatest markets in the world in medicine sales,
but presents little innovation, increasing expenses with health in the country. Due to the high
risks and costs inherent to this kind of innovation, countries considered innovation-driven,
such as the USA, commonly establish partnerships between pharmaceutical companies and
universities for achieving new therapeutic options; in Brazil, this strategy is little used,
though some actions in this field have already brought good results in the area. Deemed as a
milestone, the Innovation Law, together with other initiatives of economic subvention, is seen
by the Ministry of Health as the great strategic promise in the field of drugs and medicines.
Through exploratory research, the current study investigated the impact of the Innovation Act
in the sector and how pharmaceutical industries evaluate universities as strategic partners for
medicine research and development. Through questionnaires sent to private pharmaceutical
companies and to Núcleos de Inovação Tecnológica (Centers for Technological Innovation)
(NITs), the results enabled to ponder about the relation among industry, government, and
university in the promotion of medicine innovation in Brazil. Aspects related to the
management model to be stimulated, the influence of governmental initiatives, criteria
considered by companies for creating these partnerships, as well as activities that must be
developed by NITs for the success of this type of alliance, are discussed in the present survey.
[Texto sem Formatação]
[Texto sem Formatação]
Document type
DissertaçãoFormat
application/pdf
Subject(s)
Estratégia empresarialInovação tecnológica
Indústria farmacêutica
Medicamento
Brasil
Estratégia competitiva
Parceria universidade-indústria farmacêutica
Hélice-tríplice
Lei da Inovação
Governo
Competitive strategy innovation
University pharmaceutical industry partnership
Triple helix
Innovation
Innovation act
Medicine
Governanment
CNPQ::ENGENHARIAS::ENGENHARIA DE PRODUCAO